Future Prospects of the Global Platelet Rich Plasma Market Through 2035
While clinical interest in autologous biological therapies remains high, standardizing treatment parameters is essential for long-term clinical adoption. Regulatory bodies and international medical associations are working to establish universal classification systems and rigorous quality standards for point-of-care biological products. Establishing clear guidelines regarding platelet...
0 Comments 0 Shares 57 Views 0 Reviews